These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1083288)

  • 1. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
    Noguchi S; Bukowski R; Deodhar S; Hewlett JS
    Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T or B cell origin of some non-Hodgkin's lymphomas.
    Peter CR; MacKenzie MR; Glassy FJ
    Lancet; 1974 Sep; 2(7882):686-9. PubMed ID: 4142961
    [No Abstract]   [Full Text] [Related]  

  • 5. Nodular lymphocyte predominance type of Hodgkin's disease is a B cell lymphoma.
    Poppema S; Timens W; Visser L
    Adv Exp Med Biol; 1985; 186():963-9. PubMed ID: 2931963
    [No Abstract]   [Full Text] [Related]  

  • 6. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased numbers of lymphocytes with single class surface immunoglobulins in Hodgkin's disease.
    Bain GO; Bain VG
    Am J Clin Pathol; 1984 Dec; 82(6):674-7. PubMed ID: 6439030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of surface markers in non-Hodgkin's lymphoma by using anti-T and anti-B lymphocyte sera.
    Yamanaka N; Ishii Y; Koshiba H; Mikuni C; Ogasawara M; Kikuchi K
    Cancer; 1981 Jan; 47(2):311-8. PubMed ID: 7006795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
    Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
    Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proportion of B- and T-lymphocytes in lymph nodes removed from patients with Hodgkin's disease].
    PluzzaĊ„ska A; Robak T; Szadowska A; Kabza R; Tume Z; Maciejczyk J; Mazurowa A
    Acta Haematol Pol; 1978; 9(1):19-24. PubMed ID: 307324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
    Brubaker DB; Whiteside TL; Hartsock RJ
    Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement receptor B lymphocytes in nodular sclerosing Hodgkin's disease.
    Cossman J; Deegan MJ; Schnitzer B
    Cancer; 1977 May; 39(5):2166-73. PubMed ID: 322853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.
    Kinoshita K; Kamihira S; Ikeda S; Yamada Y; Muta T; Kitamura T; Ichimaru M; Matsuo T
    Cancer; 1982 Oct; 50(8):1554-62. PubMed ID: 6981451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
    Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
    Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histological and immunological study of patients with lung and digestive tract tumors. Analysis of T and B lymphocytes from the peripheral blood and from the lymph nodes draining the tumor (author's transl)].
    Franchi F; Colizza S; D'Amelio R; Corelli G; Bigliocchi S; Indinnimeo M; Aiuti F
    Tumori; 1975; 61(6):547-57. PubMed ID: 1083574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.